A baseline Prostate MRI PI-RADS score provides critical prognostic information for patients choosing active surveillance (AS) for prostate cancer. This imaging tool helps clinicians identify individuals at a higher risk of disease progression. Recent evidence indicates that PI-RADS scores are not just for initial detection. Instead, they serve as vital markers for predicting future Gleason Grade Group (GG) upgrades. Therefore, urologists should prioritize these scores when counseling patients on their surveillance journey.

Identifying Risks with Prostate MRI PI-RADS

A comprehensive meta-analysis involving over 6,300 patients evaluated the association between imaging scores and disease progression. The study found that nearly half of the patients on active surveillance presented with PI-RADS 4-5 lesions at baseline. These high-scoring lesions were associated with a significant increase in risk. Specifically, patients with PI-RADS 4-5 lesions demonstrated a hazard ratio of 2.21 for Gleason upgrades compared to those with PI-RADS 1-3. Consequently, these findings suggest that more aggressive monitoring may be necessary for this subgroup.

Furthermore, the data showed that higher PI-RADS scores correlate with shorter upgrade-free survival. While active surveillance remains a safe option for many, the baseline imaging provides a window into the biological behavior of the tumor. Clinicians can use this data to refine follow-up protocols. For instance, patients with PI-RADS 4-5 might benefit from earlier repeat biopsies or more frequent MRI scans. However, the retrospective nature of some studies suggests that we still need prospective validation to solidify these clinical pathways.

FAQs

How does the Prostate MRI PI-RADS score affect active surveillance?

Patients with a baseline PI-RADS 4-5 score have more than double the risk of experiencing a Gleason upgrade during active surveillance compared to those with lower scores. This makes the score a powerful predictor of which patients might eventually need active treatment.

Does a high PI-RADS score mean active surveillance is not an option?

Not necessarily. However, it indicates a higher likelihood of progression. Patients with high scores should be monitored more closely and informed about the increased possibility of upgrading to a higher Gleason Grade Group during their follow-up.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Professional medical guidance should always be sought for specific health concerns. Refer to the latest local and national guidelines for clinical practice.

References

Smani S et al. Association between baseline prostate MRI PI-RADS classification and risk of Gleason upgrade during active surveillance: a systematic review and meta-analysis. World J Urol. 2026 Feb 15. doi: 10.1007/s00345-026-06278-4. PMID: 41691567.

Mottet N et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. European Association of Urology Guidelines. 2024.